Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMA0076 Phase 2a in Glaucoma/OHT
NCT02136940Phase 2Completed
- Sponsor
- Amakem
- Start
- Apr 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AMA0076 in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Amakem. Started Apr 2014; status: completed.
02
Drugs
AMA0076
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT02136940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02136940.